WHY ORBIS?

Access Resource Library

CAPABILITIES

EXTENDED RELEASE PARENTERALS

EXTENDED RELEASE PARENTERALS

Extended release capability for small molecules, peptides, and proteins

PULSE RELEASE PARENTERALS

PULSE RELEASE PARENTERALS

Pulse release capability for vaccines and special delivery mechanisms

INTRATYMPANIC DELIVERY

INTRATYMPANIC DELIVERY

Delivery of therapeutic agents for treatment of otolaryngological diseases

ENTERIC-COATED ORAL POWDERS

ENTERIC-COATED ORAL POWDERS

A wide range of modified release options using format flexible powders

TASTE-MASKED ORAL POWDERS

TASTE-MASKED ORAL POWDERS

Don’t sacrifice taste to get a dispersed solid oral dosage form

Oral suspensions

EXTENDED RELEASE ORAL SUSPENSIONS

Match extended release tablet performance in a suspension format

TECHNOLOGY

NOT YOUR EVERYDAY NOZZLE PROCESS

Technology scale

HOW IT WORKS

Precision Particle Fabrication® technology produces uniform microspheres and microcapsules with narrow size distribution and precise control over particle structure. Orbis’ technology is an elegant and robust solution…

Read More
Techonology and how it works

SCALE & MANUFACTURING

Orbis’ platform technologies have been scaled from single nozzles to variations of multi-nozzles, then another order of magnitude by simply running multi-nozzles in parallel. Housed in Orbis’ Class 100,000 (ISO 8) production suite pictured below…

Read More

PIPELINE

Orbis Biosciences has a diverse product portfolio to leverage where Precision Particle Fabrication® technology differentiates products.

We are focused on creating novel oral and injectable therapeutics to improve compliance and patient satisfaction. Our products address clinical needs and are at various stages of development. Many of the products are based on strategic partnerships with pharmaceutical companies. Products developed internally are positioned for co-development and licensing arrangements.

See pipeline

PRESS RELEASES

Adare Pharmaceuticals, Inc. Acquires Orbis Biosciences

 Kansas-based pharmaceutical technology company develops customized formulations and intellectual propertyDeal includes platforms that can be dosed in oral, injectable and otic (ear) formulationsAcquisition expands Adare’s [...]